MarketCap
Facebook
X
TelegramGeschäftsbericht 2025
hinzugefügt 16.03.2026
Land |
 Vereinigte Staaten |
IPO-Jahr |
- |
Branche |
Pharmaeinzelhändler |
Börse |
NYSE AMERICAN |
Anteile |
2.16 M |
Marktkapitalisierung |
$ 1.38 M |
EBITDA (LTM) |
$ -13.5 M |
P/E (LTM) |
-0.04 |
P/S (LTM) |
11.16 |
EPS (LTM) |
-16.5 |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
- | 2.43 % | $ 254 M | Nasdaq Global Select Market |  Germany |
 |
AgeX Therapeutics
AGE
|
- | -10.17 % | $ 12.2 K | NYSE American | USA |
 |
I-Mab
IMAB
|
- | - | $ 866 M | Nasdaq Global Select Market |  China |
 |
Midatech Pharma plc
MTP
|
- | -18.52 % | $ 27.3 M | Nasdaq Global Select Market |  Britain |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
- | - | $ 40.3 B | Nasdaq Global Select Market | USA |
 |
Biophytis SA
BPTS
|
- | -13.47 % | $ 169 M | Nasdaq Capital Market |  France |
 |
Genfit SA
GNFT
|
- | 2.54 % | $ 160 B | Nasdaq Global Select Market | France |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
- | -1.52 % | $ 24.7 M | Nasdaq Capital Market | USA |
 |
Esperion Therapeutics
ESPR
|
$ 3.13 | 0.16 % | $ 651 M | Nasdaq Global Market,SPB | USA |
 |
Exelixis
EXEL
|
$ 46.2 | 4.01 % | $ 12.5 B | Nasdaq Global Select Market,SPB | USA |
 |
Athira Pharma
ATHA
|
- | - | $ 269 M | Nasdaq Global Select Market | USA |
 |
Fortress Biotech
FBIO
|
$ 2.49 | 1.22 % | $ 69.5 M | Nasdaq Capital Market | USA |
 |
Fennec Pharmaceuticals
FENC
|
$ 6.85 | 1.93 % | $ 196 M | Nasdaq Capital Market | USA |
 |
Galectin Therapeutics
GALT
|
$ 2.28 | 2.24 % | $ 146 M | Nasdaq Global Select Market | USA |
 |
Galapagos NV
GLPG
|
$ 28.82 | 1.51 % | $ 2.69 B | Nasdaq Global Select Market |  Belgium |
 |
Grifols, S.A.
GRFS
|
$ 8.4 | 1.51 % | $ 6.83 B | Nasdaq Global Select Market |  Spain |
 |
Genprex
GNPX
|
$ 0.89 | 0.28 % | $ 830 K | Nasdaq Capital Market | USA |
 |
BioNTech SE
BNTX
|
$ 94.21 | -1.35 % | $ 27.2 B | Nasdaq Global Select Market | Germany |
 |
InflaRx N.V.
IFRX
|
$ 2.37 | 20.05 % | $ 152 M | Nasdaq Global Select Market | Germany |
 |
Immuron Limited
IMRN
|
$ 0.82 | 3.97 % | $ 6.82 M | Nasdaq Global Select Market |  Australia |
 |
Институт стволовых клеток человека
ISKJ
|
- | - | - | MOEX |  Russia |
 |
Checkmate Pharmaceuticals
CMPI
|
- | - | $ 231 M | Nasdaq Global Market | USA |
 |
Ionis Pharmaceuticals
IONS
|
$ 76.34 | 1.45 % | $ 12.2 B | Nasdaq Global Select Market,SPB | USA |
 |
Innate Pharma S.A.
IPHA
|
$ 1.49 | 3.83 % | $ 235 M | Nasdaq Global Select Market | France |
 |
INmune Bio
INMB
|
$ 1.51 | -1.95 % | $ 37.4 M | Nasdaq Capital Market | USA |
 |
Kamada Ltd.
KMDA
|
$ 8.31 | 1.22 % | $ 260 M | Nasdaq Global Select Market |  Israel |
 |
Kymera Therapeutics
KYMR
|
$ 85.92 | 3.88 % | $ 7.26 B | Nasdaq Global Market | USA |
 |
Kazia Therapeutics Limited
KZIA
|
$ 12.98 | -3.53 % | $ 1.72 B | Nasdaq Global Select Market | Australia |
 |
ACADIA Pharmaceuticals
ACAD
|
$ 23.02 | 2.98 % | $ 3.81 B | Nasdaq Global Select Market,SPB | USA |
 |
Liquidia Corporation
LQDA
|
$ 41.73 | 3.97 % | $ 3.59 B | Nasdaq Capital Market | USA |
 |
Advaxis
ADXS
|
- | -9.65 % | $ 45.9 M | Nasdaq Capital Market | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
$ 3.56 | 1.71 % | $ 5.86 M | NYSE American | Israel |
 |
Aeterna Zentaris
AEZS
|
- | 5.93 % | $ 314 M | Nasdaq Capital Market |  Canada |
 |
Aeglea BioTherapeutics
AGLE
|
- | - | $ 1.01 B | Nasdaq Global Market | USA |
 |
Mirum Pharmaceuticals
MIRM
|
$ 106.77 | 0.9 % | $ 5.36 B | Nasdaq Global Select Market | USA |
 |
CureVac N.V.
CVAC
|
- | - | $ 867 M | Nasdaq Global Market | Germany |
 |
Applied Genetic Technologies Corporation
AGTC
|
- | - | $ 26.5 M | Nasdaq Global Select Market | USA |
 |
MannKind Corporation
MNKD
|
$ 3.88 | 35.49 % | $ 1.19 B | Nasdaq Global Market | USA |
 |
AIkido Pharma
AIKI
|
- | 1.93 % | $ 17.4 M | Nasdaq Capital Market | USA |
 |
Mereo BioPharma Group plc
MREO
|
$ 0.27 | -3.84 % | $ 660 M | Nasdaq Global Select Market | Britain |
 |
Akero Therapeutics
AKRO
|
- | - | $ 3.67 B | Nasdaq Global Select Market,SPB | USA |
 |
Aptose Biosciences
APTO
|
- | -45.71 % | $ 1.2 M | Nasdaq Capital Market | Canada |
 |
Aptinyx
APTX
|
- | -39.0 % | $ 4.57 M | Nasdaq Global Select Market | USA |
 |
Akouos
AKUS
|
- | 0.23 % | $ 488 M | Nasdaq Global Select Market | USA |
 |
Albireo Pharma
ALBO
|
- | -0.23 % | $ 916 M | Nasdaq Capital Market | USA |
 |
Allakos
ALLK
|
- | - | $ 28.6 M | Nasdaq Global Select Market,SPB | USA |
 |
AlloVir
ALVR
|
- | 4.14 % | $ 49.1 M | Nasdaq Global Select Market | USA |
 |
Arcutis Biotherapeutics
ARQT
|
$ 23.63 | 0.9 % | $ 3.01 B | Nasdaq Global Select Market,SPB | USA |
 |
Nanobiotix S.A.
NBTX
|
$ 39.36 | 13.2 % | $ 286 B | Nasdaq Global Select Market | France |
 |
Allena Pharmaceuticals
ALNA
|
- | 3.16 % | $ 1.9 M | Nasdaq Global Select Market | USA |